INFORMED.
LIVE

RUBICON RESEARCH LIMITED

BSE: RUBICON544578ISIN INE506V01022
  • Healthcare
  • Pharmaceuticals
  • BSE 1000

Share price

₹1,753.80-23.35 (-1.31%)
as of 18 Sep 2026
RUBICON RESEARCH LIMITED share price, 16 Oct 2025 to 18 Sep 2026: ₹627.45 to ₹1,753.80 (+179.5%). Low ₹589.90, high ₹1,861.15. Volume shown below the price.
52W high
₹1,896.15
52W low
₹571.00
Off 52W high
-7.51%
1M return
-2.44%
3M return
+28.96%
6M return
+124.07%
1Y return
20D avg volume
6,87,694
50 DMA
₹1,653.00
200 DMA
₹1,073.66

Key ratios Consolidated

Market cap
₹29,031 Cr
Current price
₹1,753.80
52W high / low
₹1,896.15 / ₹571.00
Face value
₹1.00
P/E
100.64
P/B
EPS (TTM)
₹17.43
Book value / share
ROE
ROCE
24.30%
Operating margin
Net margin
Debt / equity
0.20
Net debt
₹73.72 Cr
Interest cover
8.60
Dividend yield
0.09%
Dividend / share (TTM)
₹1.50
Payout
8.61%
Cash conversion cycle
179.1 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q4 FY25
Income statement
534.34513.91475.53412.02
5.682.613.790.70
429.65417.84388.73341.01
153.93155.18183.59142.18
22.0944.9621.7921.21
85.6768.3566.3763.36
9.2910.369.7711.42
15.1412.2711.5511.87
150.59157.55143.77127.80
110.3798.6990.5971.70
0.000.000.000.00
110.3798.6990.5971.70
25.5921.9017.7917.85
84.7876.7872.8053.85
5.134.664.463.49
Key metrics
134.80121.32111.9194.99
25.20%23.60%23.50%23.10%
15.90%14.90%15.30%13.10%
7.30%9.30%
MetricTTMFY26FY25
Income statement
1,9361,754
12.787.73
1,5771,441
634.88615.10
110.0591.32
283.75256.29
40.8442.17
50.8345.26
579.71541.38
371.35320.53
0.000.00
371.35320.53
83.1373.80
288.21246.74
17.7415.52
Key metrics
463.02407.96
23.92%23.30%
14.89%14.10%
24.30%
-24.12
0.83
0.20
73.72
179.1
Balance sheet
2,327
1,682
185.65
508.71
728.99
83.04
467.35
377.46
835.87
259.37
116.35
143.02
1,289
Cash flow
205.05
-409.72
283.07
229.17
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q4 FY25
Income statement
427.73389.88301.71336.47
2.413.584.301.51
319.48299.27256.48276.35
125.45122.81101.83114.43
0.000.000.000.00
51.5242.7443.6540.75
6.015.407.519.21
10.5710.179.519.78
115.92124.86104.8899.15
110.6694.1949.5361.63
0.000.000.000.00
110.6694.1949.5361.63
28.2124.1612.3515.82
82.4570.0237.1845.81
4.994.252.282.97
Key metrics
127.24109.7666.5580.62
29.70%28.20%22.10%24.00%
19.30%18.00%12.30%13.60%
6.60%7.40%
MetricTTMFY26FY25
Income statement
1,4561,306
11.8010.83
1,1521,064
464.52453.09
0.000.00
178.66164.26
28.1330.96
40.0337.75
444.81411.43
316.01252.78
0.000.00
316.01252.78
80.5464.61
235.46188.16
14.4911.83
Key metrics
384.17321.49
26.39%24.60%
16.17%14.40%
18.70%
-155.84
0.21
0.19
167.59
223.4
Balance sheet
1,976
1,414
91.78
713.43
347.82
70.26
406.13
261.86
456.81
259.37
116.35
143.02
1,353
Cash flow
38.71
-271.79
296.72
194.55

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
59.76%
HolderTypeHoldingPreviousChange
General Atlantic Singapore Rr Pte LtdPromoter35.83%
Shivanand Shankar Mankekar HUFPublic13.52%
Surabhi Parag SanchetiPromoter7.92%
Sumant PilgaonkarPromoter7.90%
Sudhir D PilgaonkarPromoter3.89%
Pratibha Sudhir PilgaonkarPromoter3.89%
Amansa Investments LtdPublic3.12%
Kotak Midcap FundPublic2.85%
Motilal Oswal Small Cap FundPublic1.73%
Fidelity Funds - India Focus FundPublic1.42%
Nomura Funds Ireland Public Limited Company- Nomura Funds Ireland - India Equity FundPublic1.35%
Bajaj Finserv Flexi Cap FundPublic1.33%
Narendra Narhar BorkarPublic1.07%
Terentia Venture PartnersPromoter Group0.31%
Parag Suganchand SanchetiPromoter0.02%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Final Dividend - Rs. - 1.50007 Aug 20267 Aug 2026

Board meetings

  • Board Meeting - Financial Results